Calamos Advisors LLC - EXAGEN INC ownership

EXAGEN INC's ticker is XGN and the CUSIP is 30068X103. A total of 36 filers reported holding EXAGEN INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Calamos Advisors LLC ownership history of EXAGEN INC
ValueSharesWeighting
Q3 2021$160,000
-60.7%
11,768
-56.6%
0.00%
-50.0%
Q2 2021$407,000
-78.2%
27,141
-74.6%
0.00%
-80.0%
Q1 2021$1,871,000
+889.9%
106,947
+512.0%
0.01%
+900.0%
Q3 2020$189,000
-70.0%
17,474
-65.6%
0.00%
-75.0%
Q2 2020$631,000
-66.8%
50,794
-57.3%
0.00%
-73.3%
Q1 2020$1,898,000
-65.5%
119,071
-45.1%
0.02%
-44.4%
Q4 2019$5,505,000
+136.9%
216,802
+44.6%
0.03%
+107.7%
Q3 2019$2,324,000149,9770.01%
Other shareholders
EXAGEN INC shareholders Q4 2020
NameSharesValueWeighting ↓
HighTower Trust Company, N.A. 2,683,578$231,056,00024.22%
Stonepine Capital Management, LLC 1,260,387$7,235,0003.37%
PERKINS CAPITAL MANAGEMENT INC 236,975$1,360,0001.41%
COWEN AND COMPANY, LLC 1,355,414$7,780,0000.75%
Penbrook Management LLC 88,100$506,0000.40%
RTW INVESTMENTS, LP 1,025,002$5,884,0000.15%
PLATINUM INVESTMENT MANAGEMENT LTD 400,000$2,296,0000.09%
Nantahala Capital Management 156,135$896,0000.04%
First Bank & Trust 23,176$133,0000.04%
WASATCH ADVISORS LP 1,011,945$5,809,0000.04%
View complete list of EXAGEN INC shareholders